Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Bioactive Compounds

Bioactive Compounds

Items 8281-8290 of 12128

Page
per page
  1. SB1317
    A3794 SB1317
    Summary: CDK,JAK and FLT inhibitor
      insoluble in H2O; ≥44.87 mg/mL
  2. SU5416
    A3847 SU5416
     9 Citation
    Target: VEGFR
    Summary: VEGFR2 inhibitor
      insoluble in EtOH; insoluble in H2O; ≥11.9 mg/mL
  3. Voreloxin
    A3924 Voreloxin
    Summary: Topo II inhibitor
      insoluble in H2O; insoluble in EtOH; insoluble in DMSO
  4. 3-Azetidinemethanol hydrochloride
    A4702 3-Azetidinemethanol hydrochloride
      ≥19.6 mg/mL
  5. 2,6-Dichlorodiphenylamine
    C6853 2,6-Dichlorodiphenylamine
      ≥45.5 mg/mL
  6. Lawsone
    C6962 Lawsone
      ≥35.6 mg/mL
  7. 5-Methoxysalicylic acid
    C7164 5-Methoxysalicylic acid
      ≥31.2 mg/mL
  8. Fomc-Gly-Gly-Phe-Gly-OH
    BA2403 Fomc-Gly-Gly-Phe-Gly-OH
    Summary: Fomc-Gly-Gly-Phe-Gly-OH can be used as an intermediate in the synthesis of ADCdual-drug-linker.
  9. 3-Methoxytyramine-d4 HCl
    SL1016 3-Methoxytyramine-d4 HCl
    Summary: A stable isotope deuterated compound of 3-Methoxytyramine HCl
  10. Ivachtin
    A4417 Ivachtin
    Summary: Caspase-3 inhibitor
      soluble in DMSO or DMF

Items 8281-8290 of 12128

Page
per page